Related Experiment Video
Updated: Jun 5, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Apoptosis and oncogenesis: give and take in the BCL-2 family
Fabien Llambi1, Douglas R Green
1Department of Immunology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 39105, USA.
Abstract:
The mitochondrial pathway of apoptosis constitutes one of the main safeguards against tumorigenesis. The BCL-2 family includes the central players of this pathway that regulate cell fate through the control of mitochondrial outer membrane permeabilization (MOMP), and important progress has been made in understanding the dynamic interactions between pro-apoptotic and anti-apoptotic BCL-2 proteins. In particular, recent studies have delineated a stepwise model for the induction of MOMP. BCL-2 proteins are often dysregulated in cancer, leading to increased survival of abnormal cells; however, recent studies have paradoxically shown that apoptosis induction can under some circumstances drive tumor formation, perhaps by inducing compensatory proliferation under conditions of cellular stress. These observations underline the complexity of BCL-2 protein function in oncogenesis.
Insights
The BCL-2 protein family regulates apoptosis, a key process in preventing cancer. Dysregulation of these proteins in cancer can paradoxically promote tumor formation, highlighting their complex role in oncogenesis.
Area of Science:
- Cellular biology
- Molecular oncology
- Cancer research
Background:
- The mitochondrial pathway of apoptosis is crucial for preventing cancer.
- BCL-2 family proteins are central regulators of this pathway, controlling mitochondrial outer membrane permeabilization (MOMP).
- Understanding the interactions between BCL-2 proteins is key to comprehending cell fate decisions.
Purpose of the Study:
- To explore the complex role of BCL-2 proteins in cancer.
- To investigate the paradoxical observation that apoptosis induction can sometimes drive tumor formation.
- To elucidate the function of BCL-2 proteins in oncogenesis.
Main Methods:
- Review of recent studies on BCL-2 protein interactions.
- Analysis of the stepwise model for MOMP induction.
- Examination of BCL-2 protein dysregulation in cancer.
Main Results:
- Recent studies have detailed a stepwise model for MOMP induction.
- BCL-2 proteins are frequently dysregulated in cancer, promoting cancer cell survival.
- Paradoxically, apoptosis induction can sometimes promote tumor formation via compensatory proliferation.
Conclusions:
- BCL-2 protein function in oncogenesis is complex and multifaceted.
- Dysregulated apoptosis and compensatory proliferation contribute to tumor development.
- Further research is needed to fully understand the role of BCL-2 proteins in cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Caspases
